Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus.
作者信息
Vengerovskii A I, Khazanov V A, Eskina K A, Vasilyev K Yu
机构信息
Department of Pharmacology, Siberian State Medical University, Tomsk.
出版信息
Bull Exp Biol Med. 2007 Jul;144(1):53-6. doi: 10.1007/s10517-007-0252-2.
PMID:18256751
Abstract
Silymarin (70 mg/kg) and succinic acid (50 mg/kg) reduce blood glucose and cholesterol concentrations, inhibit LPO, and correct oxidative phosphorylation disturbances in liver mitochondria in experimental diabetes mellitus induced by injection of streptozotocin (65 mg/kg) in rats.
摘要
Zotero 插件